Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Igari, Atsuko ^a   Nakagawa, Terumichi ^a   Moriki, Takanori ^b   Yamaguchi, Yusuke ^a   Matsumoto, Masanori ^c   Fujimura, Yoshihiro ^c   Soejima, Kenji ^d   Murata, Mitsuru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

ADAMTS13; Epitope mapping; Monoclonal antibody

Indexed keywords

MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIOPHAGE; CATALYSIS; CHEMICAL STRUCTURE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SCREENING TEST;

ADAM PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPE MAPPING; EPITOPES; MICE; VON WILLEBRAND FACTOR;

EID: 84865261272     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.006     Document Type: Article

References (29)

1. J.E. Sadler Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura Blood 112 2008 11 18
2. X. Zheng, D. Chung, T.K. Takayama, E.M. Majerus, J.E. Sadler, and K. Fujikawa Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem 276 2001 41059 41063
3. J.F. Dong Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions J Thromb Haemost 3 2005 1710 1716
4. X. Zheng, K. Nishio, E.M. Majerus, and J.E. Sadler Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13 J Biol Chem 278 2003 30136 30141
5. K. Soejima, M. Matsumoto, K. Kokame, H. Yagi, H. Ishizashi, and H. Maeda ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage Blood 102 2003 3232 3237
6. E.M. Majerus, P.J. Anderson, and J.E. Sadler Binding of ADAMTS13 to von Willebrand factor J Biol Chem 280 2005 21773 21778
7. J. Ai, P. Smith, S. Wang, P. Zhang, and X.L. Zheng The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor J Biol Chem 280 2005 29428 29434
8. M. Akiyama, S. Takeda, K. Kokame, J. Takagi, and T. Miyata Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor Proc Natl Acad Sci U S A 106 2009 19274 19279
9. P. Zhang, W. Pan, A.H. Rux, B.S. Sachais, and X.L. Zheng The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow Blood 110 2007 1887 1894
10. H.B. Feys, P.J. Anderson, K. Vanhoorelbeke, E.M. Majerus, and J.E. Sadler Multi-step binding of ADAMTS-13 to von Willebrand factor J Thromb Haemost 7 2009 2088 2095
11. S. Zanardelli, A.C. Chion, E. Groot, P.J. Lenting, T.A. McKinnon, and M.A. Laffan A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF Blood 114 2009 2819 2828
12. K. Soejima, H. Nakamura, M. Hirashima, W. Morikawa, C. Nozaki, and T. Nakagaki Analysis on the molecular species and concentration of circulating ADAMTS13 in blood J Biochem 139 2006 147 154
13. I. Kuwabara, H. Maruyama, Y.G. Mikawa, R.I. Zuberi, F.T. Liu, and I.N. Maruyama Efficient epitope mapping by bacteriophage lambda surface display Nat Biotechnol 15 1997 74 78
14. T. Moriki, I.N. Maruyama, A. Igari, Y. Ikeda, and M. Murata Identification of ADAMTS13 peptide sequences binding to von Willebrand factor Biochem Biophys Res Commun 391 2010 783 788
15. Y. Yamaguchi, T. Moriki, A. Igari, T. Nakagawa, H. Wada, and M. Matsumoto Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura Thromb Res 128 2011 169 173
16. M. Uemura, K. Tatsumi, M. Matsumoto, M. Fujimoto, T. Matsuyama, and M. Ishikawa Localization of ADAMTS13 to the stellate cells of human liver Blood 106 2005 922 924
17. S. Kato, M. Matsumoto, T. Matsuyama, A. Isonishi, H. Hiura, and Y. Fujimura Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity Transfusion 46 2006 1444 1452
18. K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 2005 93 100
19. S. Gerhardt, G. Hassall, P. Hawtin, E. McCall, L. Flavell, and C. Minshull Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains J Mol Biol 373 2007 891 902
20. H.S. Shieh, K.J. Mathis, J.M. Williams, R.L. Hills, J.F. Wiese, and T.E. Benson High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2) J Biol Chem 283 2008 1501 1507
21. L. Mosyak, K. Georgiadis, T. Shane, K. Svenson, T. Hebert, and T. McDonagh Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5 Protein Sci 17 2008 16 21
22. C. Klaus, B. Plaimauer, J.D. Studt, F. Dorner, B. Lämmle, and P.M. Mannucci Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura Blood 103 2004 4514 4519
23. B.M. Luken, E.A. Turenhout, J.J. Hulstein, J.A. Van Mourik, R. Fijnheer, and J. Voorberg The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura Thromb Haemost 93 2005 267 274
24. B.M. Luken, P.H. Kaijen, E.A. Turenhout, J.A. Kremer Hovinga, J.A. van Mourik, and R. Fijnheer Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura J Thromb Haemost 4 2006 2355 2364
25. B.M. Luken, E.A. Turenhout, P.H. Kaijen, M.J. Greuter, W. Pos, and J.A. van Mourik Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP Thromb Haemost 96 2006 295 301
26. W. Pos, J.T. Crawley, R. Fijnheer, J. Voorberg, D.A. Lane, and B.M. Luken An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF Blood 115 2010 1640 1649
27. X.L. Zheng, H.M. Wu, D. Shang, E. Falls, C.G. Skipwith, and S.R. Cataland Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura Haematologica 95 2010 1555 1562
28. W. Pos, N. Sorvillo, R. Fijnheer, H.B. Feys, P.H. Kaijen, and G. Vidarsson Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain Haematologica 96 2011 1670 1677
29. D. Li, J. Xiao, M. Paessler, and X.L. Zheng Novel recombinant glycosylphosphatidylinositol(GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura Thromb Haemost 106 2011 947 958